Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2106 (LINC02106)

Target
LINC02106
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Non-protein coding RNA
01

Overview

Long intergenic non-protein coding RNA 2106 (LINC02106) is a long non-coding RNA (lncRNA) of the lincRNA subclass, meaning it is a transcript over 200 nucleotides in length that does not overlap with protein-coding genes and does not encode a protein[1][7]. Its functions are not specifically described in the current literature, and there is no direct association with disease roles, therapeutic targeting, biomarkers, or drug interactions based on available data. Like other lincRNAs, it may play a regulatory role in gene expression, chromatin organization, or interaction with RNA-binding proteins, although these are speculative generalizations for the class and not specific for LINC02106[1][5][7]. There is no evidence to suggest that LINC02106 is currently a therapeutic target or has an established role in pathology.

Other names
CTD-2089N3.2LINC02106
02

Biological functions

Gene regulation (general for lincRNAs)Chromatin remodeling (general for some lincRNAs)Possible role in transcriptional and epigenetic regulation (general family activity)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2106 (LINC02106).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2106 (LINC02106).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call